18F-fluorodeoxyglucose positron emission tomography and rest myocardial perfusion imaging in non-granulomatous myocarditis
European Journal of Nuclear Medicine and Molecular Imaging · 2026-08 · 53 (10) · 6009-6021
DOI: 10.1007/s00259-026-07960-w ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 27.05.2026. Verfasst von Yousif A Lucinian und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Imaging, Institut de cardiologie de Montréal, 5000 Bélanger, Montréal, Québec, H1T1C8, Canada. Hauptthemen laut MEDLINE: Myocarditis, Fluorodeoxyglucose F18, Myocardial Perfusion Imaging, Positron Emission Tomography Computed Tomography. Die Arbeit nennt 34 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: Data on the use of fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) in non-granulomatous myocarditis are limited, and no study has evaluated the diagnostic performance of combined FDG-PET and rest myocardial perfusion imaging (rMPI). METHODS: We conducted a multicenter prospective observational feasibility study of patients who underwent combined FDG-PET/CT with rMPI as well as cardiac magnetic resonance (CMR) for suspected myocarditis. When available, endomyocardial biopsy (EMB) established the diagnosis according to consensus criteria. Otherwise, the final adjudicated clinical diagnosis served as the reference standard. All patients had a minimum follow-up of 12 months following PET imaging. RESULTS: Twenty-five patients were included, of whom 18 (72%) were diagnosed with myocarditis. FDG-PET and rMPI demonstrated a sensitivity/specificity of 61%/100%, and 59%/71%, respectively. Inter-reader agreement for FDG-PET was excellent (κ = 0.84, 95% CI 0.62-1.00). The combination of FDG-PET and rMPI yielded a sensitivity of 82% (95% CI: 50-93%) and a specificity of 71% (95% CI: 29-96%). Late gadolinium enhancement (LGE), excluding isolated subendocardial patterns, showed a sensitivity/specificity of 72%/57%. Spatial agreement between rMPI perfusion defects and LGE on CMR was modest (κ = 0.35, 95%CI: 0.23-0.47). CONCLUSION: Combining FDG-PET with rMPI may be a feasible imaging modality for detecting non-granulomatous myocarditis by capturing both inflammatory and fibrotic components across different disease stages.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Imaging, Institut de cardiologie de Montréal, 5000 Bélanger, Montréal, Québec, H1T1C8, Canada.
- Nuclear medicine division, Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada.
- Department of Molecular Imaging and Therapy, BC Cancer, Vancouver, BC, Canada.
- Department of Nuclear Medicine, St. Paul's Hospital, Vancouver, BC, Canada.
- Department of Medicine, Institut de cardiologie de Montréal, Montréal, Canada.
- Department of Medical Imaging, Institut de cardiologie de Montréal, 5000 Bélanger, Montréal, Québec, H1T1C8, Canada. matthieu.pelletier-galarneau@icm-mhi.org.
Zitieren
APA
Lucinian, Y. A., Martineau, P., Harel, F., Giraldeau, G., Tan, S., Juneau, D., & Pelletier-Galarneau, M. (2026). 18F-fluorodeoxyglucose positron emission tomography and rest myocardial perfusion imaging in non-granulomatous myocarditis. European Journal of Nuclear Medicine and Molecular Imaging, 53(10), 6009-6021. https://doi.org/10.1007/s00259-026-07960-w
Vancouver
Lucinian YA, Martineau P, Harel F, Giraldeau G, Tan S, Juneau D, et al. 18F-fluorodeoxyglucose positron emission tomography and rest myocardial perfusion imaging in non-granulomatous myocarditis. European Journal of Nuclear Medicine and Molecular Imaging. 2026;53(10):6009-6021. doi:10.1007/s00259-026-07960-w
BibTeX
@article{Lucinian2026,
author = {Lucinian, Yousif A and Martineau, Patrick and Harel, François and Giraldeau, Geneviève and Tan, Stéphanie and Juneau, Daniel and Pelletier-Galarneau, Matthieu},
title = {18F-fluorodeoxyglucose positron emission tomography and rest myocardial perfusion imaging in non-granulomatous myocarditis},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2026},
volume = {53},
number = {10},
pages = {6009--6021},
doi = {10.1007/s00259-026-07960-w}
}
EUVIMED